IBRX

IMMUNITYBIO INC

Healthcare | Mid Cap

-$0.10

EPS Forecast

$24.89

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2025-09-30
BEAMBeam Therapeutics IncRXRXRecursion Pharmaceuticals IncALECAlector IncKYMRKymera Therapeutics IncFATEFate Therapeutics IncALLOAllogene Therapeutics Inc